Vanberra Signal

Fizimed

Curated by Signal

Manufacturer of device for controlling urinary leakage

Overview

Fizimed manufactures a device for controlling urinary leakage. The product Emy is the wireless probe connected to a mobile application. It allows users to do the rehabilitation at home alone. The Emy biofeedback device is used in addition to the perineum reeducation sessions carried out by practitioners and allows patients to continue their exercises at home and practitioners track their work progress.

Key facts

Founded
2017
Headquarters
Strasbourg, France

Business model

Contact

Open roles

8 roles
  • Chargé(e) de supply chain et organisation opérationnelle

    Strasbourg, Grand Est, France · On-site · Volunteer

  • Chargé(e) de supply chain et organisation opérationnelle

    Strasbourg, Grand Est, France · On-site · Volunteer

  • Gestionnaire Supply Chain & opérations internes

    Strasbourg, Grand Est, France · On-site · Volunteer

+ 5 more open roles on Signal

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Developer of non-invasive continuous glucose monitoring devices

    Health TechnologyGrenoble, France
  • Provider of online medical information on pregnancy & parenting for women

    Health TechnologyParis, France
  • Provider of image analysis software for radiologists

    Health TechnologyPlouzane, France

About Fizimed

What does Fizimed do?

Fizimed manufactures a device for controlling urinary leakage.

Where is Fizimed headquartered?

Fizimed is headquartered in Strasbourg, France.

When was Fizimed founded?

Fizimed was founded in 2017.

Which sector is Fizimed in?

Fizimed operates in Health Technology.

Who are Fizimed's competitors?

Companies similar to Fizimed include Eclypia, Bliss Stories, and Intradys.

Is Fizimed hiring?

Yes. Fizimed has 8 open roles listed on Vanberra Signal.